The $453K in insider sales is economically immaterial at 0.02% of market cap, but the proximity to a restatement disclosure warrants monitoring for further insider activity. Watch for additional Form 4 filings from C-suite executives in the next 30 days — a cluster of sales would amplify the bearish signal. The restatement itself is non-cash and narrow in scope (stock-based compensation timing), so the fundamental business operations remain intact.
Price Chart
Executive Summary
Two DCO directors received non-cash stock grants (1,200 shares each at $0) on May 27, 2026, while the VP & GC and CFO sold a combined 3,100 shares on May 20 for $453K. The sales occurred just 19 days after the company disclosed a material restatement (Item 4.02) for stock-based compensation errors that overstated operating income by $13.4M and EPS by $0.87 over 2024-2025. The non-cash grants are routine compensation and carry no economic signal, but the open-market sales by two senior officers shortly after a restatement raise timing concerns.
Key Financial Metrics
Key Facts
- Two directors received non-cash stock grants of 1,200 shares each at $0 on May 27, 2026 — no economic value.
- VP & GC Tata Rajiv A. sold 1,600 shares for $234K on May 20, 2026.
- CFO Mookerji Suman B. sold 1,500 shares for $220K on May 20, 2026.
- Total open-market sales: $453K, representing ~0.02% of DCO's $2.3B market cap — below the 0.1% materiality threshold.
- Sales occurred 19 days after the May 1, 2026 8-K disclosing a restatement for stock-based compensation errors that overstated operating income by $13.4M and EPS by $0.87 over 2024-2025.
- The restatement is non-cash and does not affect revenue, gross margin, cash flow, or debt covenant compliance.
Financial Impact
Open-market sales of $453K (0.02% of market cap) are trivial in dollar terms, but the timing 19 days after a material restatement disclosure is the key concern.
Risk Factors
- Insider sales after a restatement may indicate management's lack of confidence in the restated numbers or future outlook.
- Further insider selling by additional executives could signal broader concerns.
- The restatement, while non-cash, may trigger SEC scrutiny or shareholder litigation.
- Potential negative sentiment from the restatement could pressure the stock despite no impact on cash flows.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DCO-1780087852465 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G | $165.38 | awaiting T+60 | — | $164.79 (−0.36%) |
Aug 27, 2026 8w ago | Press Release | $183.93 | awaiting T+60 | — | $164.79 (−10.41%) |
Aug 15, 2026 10w ago | Institutional Cluster | $205.23 | awaiting T+60 | — | $164.79 (−19.70%) |
Jul 23, 2026 13w ago | Press Release | $175.51 $170.59 | ▼ −2.80% | ▼ −7.36% | $164.79 (−6.11%) |
Jun 11, 2026 19w ago | Institutional Cluster | $165.00 $168.32 | ▲ +2.01% | ▼ −2.38% | $164.79 (−0.13%) |
May 22, 2026 22w ago | Insider Cluster | $150.03 $200.16 | ▼ −33.41% | ▼ −30.69% | $164.79 (−9.84%) |
May 22, 2026 22w ago | Insider Cluster | $150.03 $200.16 | ▼ −33.41% | ▼ −30.69% | $164.79 (−9.84%) |
May 20, 2026 22w ago | Insider Cluster | $142.92 $205.23 | ▼ −43.60% | ▼ −39.30% | $164.79 (−15.30%) |
May 12, 2026 24w ago | Press Release | $145.03 $201.46 | ▲ +38.91% | ▲ +34.53% | $164.79 (+13.62%) |
May 8, 2026 24w ago | 10-K/A | $137.23 $191.86 | ▼ −39.81% | ▼ −34.97% | $164.79 (−20.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers